SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007713
Filing Date
2024-03-12
Accepted
2024-03-12 19:05:19
Documents
1
Period of Report
2023-10-03

Document Format Files

Seq Description Document Type Size
1 form4-03122024_110350.html 4  
1 form4-03122024_110350.xml 4 4576
  Complete submission text file 0001415889-24-007713.txt   6129
Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address
Fischer Laurent (Reporting) CIK: 0001379344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 24743974

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)